European Institute of Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
European Institute of Oncology
Jul 26, 2024, 08:11 |
Blog
Federico Mastroleo: Choose Radiation Oncology!
Federico Mastroleo, Radiation Oncologist at IEO European Institute of Oncology, shared a post on X: "The Concorso…
Jul 19, 2024, 22:55 |
Blog
What after Osimertinib failure?
Abhishek Pathak, Professor at the Indian Army, shared a post on X: "What after Osimertinib…
Jul 12, 2024, 15:04 |
Blog
Dario Trapani: Essential part of sport that should be of inspiration 4 oncology
Dario Trapani, Medical Oncologist at European Institute of Oncology, shared on X: “There's an essential…
Jul 9, 2024, 03:40 |
Insight
Dario Trapani: Cancer in humanitarian setting
Dario Trapani, Medical Oncologist at European Institute of Oncology, shared on X: “Cancer in humanitarian setting:…
Jul 7, 2024, 17:28 |
Insight
Cristiane D. Bergerot: Unmet social needs in cancer care across HIC and LMIC
Cristiane D. Bergerot shared on X: "Our study in JCO Global Oncology explores financial toxicity…
Jun 30, 2024, 12:05 |
Insight
The situation around GEP-MiNENs in Italy
Two studies from Italy present 20-year-old real-world data on patients with GEP-MiNENs treated with chemotherapy…
Jun 26, 2024, 03:41 |
Insight
Paolo Tarantino: Opportunities to improve outcomes for early recurrent TNBC
Paolo Tarantino shared a post on X: . "Early recurrent TNBC (Triple-Negative…
Jun 23, 2024, 13:08 |
Drugs
Capivasertib is now approved in EU for HR+/HER2- breast cancer
Paolo Tarantino shared a post on X: "Capivasertib is now approved in EU for the…
Jun 21, 2024, 04:41 |
Insight
Davide Ciardiello: Cetuximab and Avelumab in patients with colorectal cancer liver metastasis
Davide Ciardiello, Oncologist at the Medical Oncology Division of Gastrointestinal and Neuroendocrine Tumors at European…
Jun 15, 2024, 16:02 |
Dialogues
Oncodaily Talks: Dialogue with Giuseppe Curigliano, hosted by Chandler Park
OncoDaily Talks gathers people worldwide to discuss challenges in cancer care. We share creative solutions…
Jun 5, 2024, 15:33 |
Insight
Giuseppe Curigliano: Excited that the DESTINY-06 trial was presented at ASCO2024
Giuseppe Curigliano shared on LinkedIn: “Excited to share that the DESTINY-06 trial was presented at…
Jun 5, 2024, 06:27 |
Blog
Giuseppe Curigliano: Proud to serve on the Educational Committee for ASCO2024
Giuseppe Curigliano shared on LinkedIn: . "Proud to serve on…
Jun 5, 2024, 04:25 |
Blog
Giuseppe Curigliano: Excited to see NBC News highlight the groundbreaking results of DESTINY-06
Giuseppe Curigliano reposted Erika Hamilton's post on LinkedIn, adding: . "Excited to see NBC…
Jun 4, 2024, 12:39 |
Blog
Giuseppe Curigliano: Together, we can achieve more!
Giuseppe Curigliano shared on LinkedIn: . "Investing in the next generation of oncologists…
Jun 2, 2024, 09:05 |
Blog
Giuseppe Curigliano: Celebrating Gender Equity and Inclusion with Dr. Don S. Dizon at ASCO24
Giuseppe Curigliano shared on LinkedIn: "Celebrating Gender Equity and Inclusion with the inspiring Dr. Don…
May 28, 2024, 14:34 |
Drugs
Paolo Tarantino: Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer
Paolo Tarantino shared on X: "Impressive activity with tucatinib plus trastuzumab for HER2-mutated breast cancer.…
May 23, 2024, 14:29 |
Societies
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced
The names of the candidates running for the ESMO Presidency 2027-2028 have been announced. Find…
May 18, 2024, 02:12 |
Blog
Paolo Tarantino: Important subanalysis of SOFT/TEXT presented by Otto Metzger
Paolo Tarantino shared on X: "Important subanalysis of SOFT/TEXT presented by Otto Metzger from Dana-Farber’s…
May 17, 2024, 15:13 |
Societies
Elisabetta Munzone: TIP poster PREcoopERA trial for premenopausal women with early breast cancer
Elisabetta Munzone, Medical oncologist and Breast Cancer specialist at the European Institute of Oncology, shared…
May 13, 2024, 07:12 |
Blog
Paolo Tarantino: DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my friend and mentor of many years Giuseppe Curigliano
Paolo Tarantino shared on X: "DESTINY-Breast06 will be presented on 6/2 at ASCO24 by my…
Apr 29, 2024, 20:00 |
Opinion
Erika Hamilton: Really feel like we don't need to be testing for HER-2 for TDXd in breast cancer
Erika Hamilton shared a post by Giuseppe Curigliano, Chief of the Clinical Division of Early…
Apr 17, 2024, 17:32 |
Blog
Pam Mangat-Dhaliwal: Thrilled to participate in the second ASCO-AIOM International Clinical Research Course
Dario Trapani, Medical oncologist at the European Institute of Oncology (IEO), shared a post by Pam Mangat-Dhaliwal, Division…
Apr 15, 2024, 13:28 |
Insight
Antonio Passaro: Release of our editorial, co-authored with Peters Solange, focusing on the groundbreaking ALINA study
Antonio Passaro, Medical Oncologist at European Institute of Oncology, shared on LinkedIn: ''I am thrilled…
Apr 2, 2024, 12:50 |
Blog
Antonio Passaro: Key milestones in cancer biomarker research and future avenues for enhancing the management of patients with solid tumors
Antonio Passaro, Medical Oncologist at the European Institute of Oncology, shared a post on LinkedIn:…
Mar 30, 2024, 11:05 |
Dialogues
The Comfort Corner #1: Dialogue with Matti Aapro, hosted by Martin Harutyunyan
Welcome to "The Comfort Corner" - a palliative care series that brings together medical professionals…
Mar 23, 2024, 15:20 |
Blog
Giuseppe Curigliano: Grateful to Stella Kyriakides Commissioner for Health at European Commission for visiting European Institute of Oncology (IEO)
Giuseppe Curigliano, Chief of the Clinical Division of Early Drug Development at European Institute of…
Jan 8, 2024, 15:10 |
Blog
Khalid El Bairi: This book is a labor of love aimed at advancing cancer research and supporting patients
Khalid El Bairi, Founder of The Cancer Biomarkers Working Group, shared a post on LinkedIn:…
Oct 2, 2023, 22:37 |
Insight
Paolo Tarantino: Antibody drug conjugates (ADCs) are leading to relevant survival improvements for multiple types of cancer.
Paolo Tarantino, MD and researcher at the European Institute of Oncology and clinical research fellow…
Aug 15, 2023, 09:15 |
Insight
Paolo Tarantino: Delivering chemo via HER2- and Trop2-targeted Antibody-drug conjugates (ADCs) has reshaped the way we treat Metastatic breast cancer (MBC)
Paolo Tarantino, MD, Clinical Research Fellow at Dana-Farber Cancer Institute, stated on Twitter: "Delivering chemo…
All:
29
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube